Catalent

^{Priced, NYSE: CTLT}

Global provider of oral, injectable and respiratory drug delivery technologies.

Industry: Health Care

First Day Return: -2.5%

CTLT

Global provider of oral, injectable and respiratory drug delivery technologies.

IPO News for Catalent

Drug making goes Dutch: Pharma outsourcer Patheon files for an IPO that could raise $700 million 06/08/15
Renaissance Capital's 3Q 2014 US IPO Market Review 10/01/14
US IPO Pricing Recap: 15 IPOs in the most active week since 2007; 66% ended at or below IPO price 08/01/14

IPO Data
IPO Date	07/30/2014
Offer Price	IPO Intelligence Only
Price Range	IPO Intelligence Only
Offer Shares (mm)	IPO Intelligence Only
Deal Size ($mm)	$871
Lock-Up Date	IPO Intelligence Only
Street Research	IPO Intelligence Only

Underwriters
IPO Intelligence Only

Company Data
Website www.catalent.com
Headquarters	Somerset, NJ, United States
Founded	2007
Employees at IPO	8,000

IPO News for Catalent

Catalent (CTLT) Performance